PharmGKB Blog
Wednesday, January 19, 2022

CPIC Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update

›
The 2022 CPIC Guideline update for CYP2C19 Genotype and Clopidogrel Therapy is now published in Clinical Pharmacology and Therapeutics . Th...
Thursday, December 16, 2021

Update to PharmGKB Pediatric Drug Summaries

›
The second round of PharmGKB's pediatric drug summaries is now live on PharmGKB pediatric , adding over 25 more drugs beyond PharmGKB...
Wednesday, December 1, 2021

Please help secure funding for PGx!!

›
The ability to predict ahead of time which drugs will be effective for a unique patient and determine which medications may cause patients s...
Wednesday, November 24, 2021

Pediatric PharmGKB User Survey

›
Similar to our PharmGKB user survey in October-November, we have launched a user survey to gather feedback about the use of our Pediatric Ph...
Tuesday, November 23, 2021

CPIC® Guideline for Potent Volatile Anesthetic Agents and Succinylcholine and RYR1 and CACNA1S update

›
The ClinGen Malignant Hyperthermia Susceptibility Variant Curation Expert Panel recently published recommendations for RYR1 pathogenicity c...
Monday, November 22, 2021

Pathways in progress, a way to accelerate the pathways visible to users

›
Thanks to user feedback regarding the PharmGKB pathways, we understand that many of our pathways are used for teaching and presentations, an...
Tuesday, November 2, 2021

Survey of PharmGKB API usage

›
PharmGKB is wholly supported by NIH (NHGRI and NICHD). As we prepare for grant renewal, we are asking users of our API to provide us with 3-...
‹
›
Home
View web version

Contributors

  • Caroline Thorn, Curator
  • Katrin Sangkuhl
  • Li Gong
  • Mark Woon
  • Mark Woon
  • Michelle Whirl-Carrillo, Director and Co-PI
  • Ryan Whaley, Technical Lead
  • Teri Klein, Co-PI PharmGKB, CPIC, PharmCAT & ClinGen
Powered by Blogger.